J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 76 (1995), 103-111; DOI 10.1099/0022-1317-76-1-103
© 1995 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ulaeto, D.
Right arrow Articles by Hruby, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ulaeto, D.
Right arrow Articles by Hruby, D. E.
Agricola
Right arrow Articles by Ulaeto, D.
Right arrow Articles by Hruby, D. E.

Brefeldin A inhibits vaccinia virus envelopment but does not prevent normal processing and localization of the putative envelopment receptor P37

David Ulaeto*, Douglas Grosenbach and Dennis E. Hruby

Department of Microbiology, Oregon State University, Corvallis, OR 97331-3804

The fungal metabolite Brefeldin A was found to inhibit the production of the infectious enveloped form of vaccinia virus, although production of the infectious intracellular form was not affected. Electron microscopic analysis and caesium chloride density centrifugation of progeny virions indicates that the drug block is not due to retention and accumulation of enveloped virions within the cell. Biochemical analysis of the candidate envelopment receptor for vaccinia virus, viral protein P37, shows that the drug has no discernible effect on palmitylation of this protein and does not prevent or alter its association with intracellular membranes. This suggests that P37 may not in fact be the receptor on intracellular membranes for vaccinia virus envelopment, and leaves open the question of what function this molecule performs in the envelopment process.

* Author for correspondence. Fax +1 503 737 2440. e-mail ulaetod@bcc.orst.edu

Received 6 July 1994; accepted 14 September 1994.


This article has been cited by other articles:


Home page
J. Virol.Home page
T. R. Wagenaar and B. Moss
Association of Vaccinia Virus Fusion Regulatory Proteins with the Multicomponent Entry/Fusion Complex
J. Virol., June 15, 2007; 81(12): 6286 - 6293.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Husain, A. S. Weisberg, and B. Moss
Existence of an operative pathway from the endoplasmic reticulum to the immature poxvirus membrane
PNAS, December 19, 2006; 103(51): 19506 - 19511.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Punjabi and P. Traktman
Cell Biological and Functional Characterization of the Vaccinia Virus F10 Kinase: Implications for the Mechanism of Virion Morphogenesis
J. Virol., February 15, 2005; 79(4): 2171 - 2190.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Husain and B. Moss
Evidence against an Essential Role of COPII-Mediated Cargo Transport to the Endoplasmic Reticulum-Golgi Intermediate Compartment in the Formation of the Primary Membrane of Vaccinia Virus
J. Virol., November 1, 2003; 77(21): 11754 - 11766.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Meiser, C. Sancho, and J. Krijnse Locker
Plasma Membrane Budding as an Alternative Release Mechanism of the Extracellular Enveloped Form of Vaccinia Virus from HeLa Cells
J. Virol., September 15, 2003; 77(18): 9931 - 9942.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Mercer and P. Traktman
Investigation of Structural and Functional Motifs within the Vaccinia Virus A14 Phosphoprotein, an Essential Component of the Virion Membrane
J. Virol., August 15, 2003; 77(16): 8857 - 8871.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. Meiser, D. Boulanger, G. Sutter, and J. Krijnse Locker
Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus release
J. Gen. Virol., June 1, 2003; 84(6): 1383 - 1392.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. Law, R. Hollinshead, and G. L. Smith
Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread
J. Gen. Virol., January 1, 2002; 83(1): 209 - 222.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
D. Boulanger, T. Smith, and M. A. Skinner
Morphogenesis and release of fowlpox virus
J. Gen. Virol., March 1, 2000; 81(3): 675 - 687.
[Abstract] [Full Text]


Home page
J. Cell Biol.Home page
M.-J. J.E. Bijlmakers and M. Marsh
Trafficking of an Acylated Cytosolic Protein: Newly Synthesized p56lck Travels to the Plasma Membrane via the Exocytic Pathway
J. Cell Biol., May 3, 1999; 145(3): 457 - 468.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-H. Baek, J.-Y. Kwak, S. H. Lee, T. Lee, S. H. Ryu, D. J. Uhlinger, and J. D. Lambeth
Lipase Activities of p37, the Major Envelope Protein of Vaccinia Virus
J. Biol. Chem., December 19, 1997; 272(51): 32042 - 32049.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. W. Grosenbach, D. O. Ulaeto, and D. E. Hruby
Palmitylation of the Vaccinia Virus 37-kDa Major Envelope Antigen. IDENTIFICATION OF A CONSERVED ACCEPTOR MOTIF AND BIOLOGICAL RELEVANCE
J. Biol. Chem., January 17, 1997; 272(3): 1956 - 1964.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1995 by the Society for General Microbiology.